More articles from Drug therapies in…

You have access
‘Designer drugs’: update on the management of novel psychoactive substance misuse in the acute care setting
Christopher D Smith and Stefanie Robert

Clin Med August 2014, DOI: https://doi.org/10.7861/clinmedicine.14-4-409
You have access
Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challenges
Gunar Günther

Clin Med June 2014, DOI: https://doi.org/10.7861/clinmedicine.14-3-279
You have access
Drug therapies in liver disease
Peter Collins, Lachlan Ayres and Talal Valliani

Clin Med December 2013, DOI: https://doi.org/10.7861/clinmedicine.13-6-585
You have access
Drug advances in inflammatory bowel disease
R Alexander Speight and John C Mansfield

Clin Med August 2013, DOI: https://doi.org/10.7861/clinmedicine.13-4-378
You have access
Frontline antibiotic therapy
Alasdair MacGowan and Maha Albur

Clin Med June 2013, DOI: https://doi.org/10.7861/clinmedicine.13-3-263
You have access
Recent advancements in the drug treatment of endocrine diseases
Amir H Sam and Karim Meeran

Clin Med April 2013, DOI: https://doi.org/10.7861/clinmedicine.13-2-170
You have access
Pharmacological treatment of chronic stable angina pectoris
Jason M Tarkin and Juan Carlos Kaski

Clin Med February 2013, DOI: https://doi.org/10.7861/clinmedicine.13-1-63
You have access
Drug therapy of inflammatory arthritis
Nicola J Gullick and David L Scott

Clin Med August 2012, DOI: https://doi.org/10.7861/clinmedicine.12-4-357

Main menu